These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20659940)

  • 41. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.
    Zhou L; Thorson JA; Nugent C; Davenport RD; Butch SH; Judd WJ
    Am J Obstet Gynecol; 2005 Dec; 193(6):1966-71. PubMed ID: 16325598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Problems of IgG-anti D administration during pregnancy].
    Hähn N; Gallasch EH; Smaluhn W; Lüthje D
    Zentralbl Gynakol; 1974 Jul; 96(29):897-904. PubMed ID: 4213693
    [No Abstract]   [Full Text] [Related]  

  • 44. [Direct and mixed Coombs' tests in children of mothers with Rh immunization].
    Burenkova LV
    Probl Gematol Pereliv Krovi; 1975 Jul; 20(7):20-3. PubMed ID: 812077
    [No Abstract]   [Full Text] [Related]  

  • 45. Positive cord blood "DAT" due to anti-Le(a): absence of hemolytic disease of the newborn.
    Abhyankar S; Silfen S; Rao SP; Vinciguerra C; Dimiaio TM
    Am J Pediatr Hematol Oncol; 1989; 11(2):184-5. PubMed ID: 2787608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.
    Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A
    BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation].
    van der Ploeg CP; Hirschberg HJ; de Haas M; Abbink F
    Ned Tijdschr Geneeskd; 2015; 159():A8315. PubMed ID: 25898866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of red cell alloimmunisation in pregnancy: the non-invasive monitoring of the disease.
    Illanes S; Soothill P
    Prenat Diagn; 2010 Jul; 30(7):668-73. PubMed ID: 20572110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interpretation of the direct antiglobulin test in neonates with haemolytic disease of the newborn.
    Tuladhar R; Patole SK; Whitehall JS
    Int J Clin Pract; 2000; 54(1):64. PubMed ID: 10750264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of positive direct antiglobulin test and clinical outcomes in Surinamese newborns from D-negative women.
    Zonneveld R; Lamers M; Schonewille H; Brand A; Kanhai HHH; Zijlmans WCWR
    Transfusion; 2017 Oct; 57(10):2496-2501. PubMed ID: 28681433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Blood group incompatibility. Introduction and serologic-genetic report].
    Speiser P
    Wien Med Wochenschr; 1970 Mar; 120(13):215-7. PubMed ID: 4105436
    [No Abstract]   [Full Text] [Related]  

  • 53. The performance of an anti D immunoprophylaxis scheme.
    Kinnock S; Liley AW
    N Z Med J; 1974 Oct; 80(526):337-43. PubMed ID: 4216865
    [No Abstract]   [Full Text] [Related]  

  • 54. Post-test probability for neonatal hyperbilirubinemia based on umbilical cord blood bilirubin, direct antiglobulin test, and ABO compatibility results.
    Peeters B; Geerts I; Van Mullem M; Micalessi I; Saegeman V; Moerman J
    Eur J Pediatr; 2016 May; 175(5):651-7. PubMed ID: 26782094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the direct antiglobulin (Coombs') test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Coombs' test with ETCOc for detecting significant jaundice.
    Herschel M; Karrison T; Wen M; Caldarelli L; Baron B
    J Perinatol; 2002; 22(5):341-7. PubMed ID: 12082466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased fetal iron load in rhesus hemolytic disease.
    Aygun C; Tekinalp G; Gurgey A
    Pediatr Hematol Oncol; 2004 Jun; 21(4):329-33. PubMed ID: 15205095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three examples of Rh haemolytic disease of the newborn with a negative direct antiglobulin test.
    Heddle NM; Wentworth P; Anderson DR; Emmerson D; Kelton JG; Blajchman MA
    Transfus Med; 1995 Jun; 5(2):113-6. PubMed ID: 7655573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The importance of immunohematology testing in the neonatal period].
    Bujandrić N; Milanović MK
    Med Pregl; 2013; 66(7-8):317-21. PubMed ID: 24069814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-D prophylaxis: past, present and future.
    de Haas M; Finning K; Massey E; Roberts DJ
    Transfus Med; 2014 Feb; 24(1):1-7. PubMed ID: 25121157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal screening of ABO/RhD blood group and direct antiglobulin Coombs test. Experience of a single institution.
    Baptista-González HA; Rodríguez-Alvarado AG; Bouchán-Valencia P; Coeto-Barona G; Coronado-Zarco IA
    Bol Med Hosp Infant Mex; 2024; 81(2):97-105. PubMed ID: 38768512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.